Astec LifeSciences share news, announcements and annual reports
NSE: ASTECBSE: 533138Fertilizers & AgrochemicalsSmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹581.05.
30 Oct: open ₹582.00, high ₹583.85, low ₹542.50
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,216 Cr1,284th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.63
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −21.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −7.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.99
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 75,77944.6% delivered
Astec LifeSciences share news and announcements
804 announcements, routine notices left out, newest first. Page 15 of 17.
Jul 2014
Jun 2014
2 Jun · Dividend
Board of Directors of the Company at its meeting held on May 30, 2014,has recommend enhanced dividend of Rupee One per share (i.e. 10% on the face value of Rs. 10/- each) for the period ended March 31, 2014, for the approval of shareholders at the ensuing Annual General Meeting as compared to Seventy Five Paise per share (i.e. 7.5% on the face value of Rs. 10/- each) which was declared for the previous year.2 Jun · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2014, has accorded its consent to issuance of securities on preferential basis way of issue of Equity Shares/ Preference Shares/ Cumulative Convertible Bonds/ Debentures not exceeding Rupee 25 Crores (shall include premium thereon) at a price which shall be determined in accordance with the Guideline of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009.
May 2014
28 May · Updates
5 May · Board meeting
Inter alia, to transact the following business: (1) To consider and approve the Standalone & Consolidated Audited Accounts for the Quarter & Year Ended March 31, 2014, after these accounts are reviewed by Audit Committee. (2). To recommend dividend on Equity shares for the year ended March 31, 2014, if any.
Apr 2014
Mar 2014
Feb 2014
Jan 2014
14 Jan · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended December 31, 2013 after these results are reviewed by the Audit Committee.14 Jan · Updates
As per the Company's Code of Conduct for Prohibition of Insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992, the Trading Window for dealing in the securities of the Company will be closed for the purpose of declaration of unaudited financial results of the Company for the Quarter ended December 31, 2013 for all the Officers and Designated Employees (including Directors) of the Company from January 15, 2014 till 24 hours after the announcement of the financial results of the Company to the Stock Exchanges (both days inclusive). Accordingly all Officers and Designated Employees (including Directors) of the Company have been intimated not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of Trading Window.
Oct 2013
14 Oct · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended September 30, 2013 after these results are reviewed by the Audit Committee.
Sep 2013
19 Sep · Board meeting
11 Sep · Board meeting
For approving the Allotment of Equity Shares pursuant to the Conversion of Preferential Warrants convertible into Equity Shares.
Aug 2013
16 Aug · Meeting
Company has fixed Book Closure from September 4, 2013 to September 6, 2013 (both days inclusive) for the purpose of Annual General Meeting scheduled to be held on September 17, 2013 & Dividend Payment.14 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 12, 2013, considered the following : Due to resignation of M/s. P. M. Kathariya & Co., Chartered Accountants as the Statutory Auditor of the Company and as the Company is already in process of appointing M/s. Shah & Kathariya as new Auditor of the Company till the conclusion of next year's Annual General Meeting, the same is subject to shareholders to accord their approval for the appointment of new auditor. Therefore, Company will submit the Limited Review Report certified by the new Auditor for the quarter ended June 30, 2013 as soon as the Appointment of New Auditor will be in place.
Jul 2013
29 Jul · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended June 30, 2013 after these results are reviewed by the Audit Committee.4 Jul · Change in Company Secretary/Compliance Officer
Ms. Tejal Jariwala is appointed as Company Secretary of the Company in place of existing Company Secretary Mr. Vikas Chomal who has resigned from the post of Company Secretary.
Jun 2013
May 2013
27 May · Board meeting
Board of Directors of the Company at its meeting held on May 24, 2013 has approved the appointment of M/s. Shah & Kathariya, Chartered Accountants, Mumbai as Statutory Auditors of the Company for the Financial Year 2013-2014 in place of retiring Auditors M/s. P. M. Kathariya & Co., Chartered Accountants. The retiring Auditors expressed their inability to continue as Statutory Auditors of the Company due to their pre-occupations.27 May · Dividend
Board of Directors of the Company at its meeting held on May 24, 2013 has Recommended a dividend of Seventy Five paise per share (i.e. 7.5% on face value of Rs. 10/- each) for the approval of the Shareholders at the ensuing Annual General Meeting.14 May · Board meeting
Inter alia, to transact the following business : (1) To consider and approve the Standalone & Consolidated Audited Annual Accounts for the Quarter & Year Ended March 31, 2013, after these accounts are reviewed by Audit Committee; (2) To recommend dividend on the Equity shares for the year ended March 31, 2013, if any.10 May · Management
Company has recently appointed Mr. Ravindra Inani as Chief Financial Officer of the Company in place of Mr. Prashnt Badheka.
Feb 2013
7 Feb · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended December 31, 2012 after these results are reveiwed by the Audit Committee.
Jan 2013
4 Jan · Board meeting
Dec 2012
27 Dec · Board meeting
For approving the Allotment of Equity Shares pursuant to the Conversion of Preferential Warrants convertible into Equity shares.
Nov 2012
3 Nov · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended September 30, 2012 after these results are reviewed by the Audit Committee.
Sep 2012
4 Sep · Meeting
Annual General Meeting of the Company will be held on September 25, 2012. The Register of Members and the Share Transfer Books of the Company will remain closed from September 17, 2012 to September 25, 2012 (both days inclusive) for the purpose of Annual General Meeting and Dividend Payment.
Aug 2012
Jul 2012
28 Jul · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended June 30, 2012 after these results are reviewed by the Audit Committee.
Jun 2012
May 2012
29 May · Management
Board of Directors of the Company at its meeting held on May 28, 2012 appointed Mr. Mandar K. Patil as Non-Executive & Independent Director on the Board of the Company and member of Audit Committee with effect from May 27, 2012.